Advertisement
New Zealand markets open in 5 hours 14 minutes
  • NZX 50

    12,638.90
    -55.94 (-0.44%)
     
  • NZD/USD

    0.5950
    -0.0026 (-0.43%)
     
  • ALL ORDS

    8,422.10
    -17.40 (-0.21%)
     
  • OIL

    69.59
    +0.98 (+1.43%)
     
  • GOLD

    2,747.90
    -52.90 (-1.89%)
     

Why AbbVie and Amgen Are Moving Lower Today

Why AbbVie and Amgen Are Moving Lower Today

Shares of the immunology juggernaut AbbVie (NYSE: ABBV) were down by 4% on sky-high volume as of 11 a.m. ET Thursday. The big loss came after Coherus Biosciences announced a partnership with billionaire Mark Cuban's pharmaceuticals start-up -- known as the Mark Cuban Cost Plus Drug Company -- to sell a biosimilar (a generic biologic) version of AbbVie's flagship anti-inflammatory medication, Humira, at an 85% discount. Coherus' biosimilar will be branded as Yusimry.